Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Compliance Corner: First Impressions Count During FDA Inspections, Ex-Investigators Say

Executive Summary

Referring to a US FDA investigator as an "inspector" might not seem like a big deal, but it is – and doing so can taint an inspection right from the start, industry insider Ricki Chase says. The former director of FDA’s Investigations Branch gives other pointers – including avoiding snatching investigator credentials and asking investigators if they're at the company to inspect the cafeteria. Another former FDA Investigations Branch director, David Chesney, chimes in, offering advice to ensure the best first impression.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT104318

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

All set! This Question has been sent to my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel